Market Place
Sourcing Support
Actavis` Generic Fidaxomicin Receives Approval in the U.S.
16 Jan 2024 //
FDA
Tillotts Pharma: DIFICLIRTM is recommended for C. difficile infection
07 Dec 2021 //
BUSINESSWIRE
Seres Therapeutics to Present SER-109 Phase 3 ECOSPOR III Study Results
12 Oct 2020 //
BUSINESSWIRE
Astellas Submits Application for Approval of fidaxomicin Infectious Enteritis
31 Jul 2017 //
ASTELLAS
After Delay, Merck Gets US Approval for Serious Infection Drug
25 Oct 2016 //
PMLIVE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.